
May 2025 (PDF for print)
Patient Demography: Male, 81 years old
Diagnosis: Metastasized adenocarcinoma of the prostate with bone marrow infiltration
Other Information: Known case of prostate adenocarcinoma and essential thrombocythemia
Microscopic Review: Neutrophils 45%, Lymphocytes 35%, Monocytes 10%, Eosinophils 1%, Metamyelocytes 9%, Erythroblast (nRBC): 4/100 WBC (orthochromatic with dyserythropoietic features). Few dysplastic/atypical nucleated cells seen.
Other Test: Non-mutated JAK2, mutated CALR. Imaging (CT) showing lymph nodes and bone involvement.
How Yumizen Can Assist: On the DIFF scattergram, we observe the presence of immature cell population and a few atypical/dysplastic cells (high % of LIC & ALY) which are not well classifiable in WBC differential. The high percentage of LIC and NRBC (with normal WBC range) on Yumizen H2500 hematology analyzer, with shift to left, along with a few dysplastic/atypical nucleated cells seen in microscopy, should think of bone marrow infiltration in this case. The patient is already a known case of adenocarcinoma of prostate, with bone metastasis.
This clinical case has been provided by the Laboratory of Portuguese Public Hospital.
HORIBA제품의 자세한 정보를 원하시면, 아래의 양식에 내용을 입력을 부탁드립니다.